Back

Notification report


Full notification file


General information

Notification Number
B/FR/13/GT07

Member State to which the notification was sent
France

Date of acknowledgement from the Member State Competent Authority
21/10/2013

Title of the Project
Use of genetically modified T-lymphocytes expressing the inducible human caspase 9 gene (iCASP9) and the selection gene ΔCD19 for the treatment of Graft versus Host Disease (GvHD) in allogeneic haematopoietic transplantation: Study Side by Cide

Proposed period of release:
01/03/2014 to 30/03/2017

Name of the Institute(s) or Company(ies)
Centre Hospitalier Universitaire de Besançon, ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Human T lymphocytes expressing the iCasp9 (suicide gene) and ΔCD19 cell surface marker (selection gene).

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
------

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known